source
- Sling Therapeutics raises $123M Series C to advance oral thyroid eye disease drugSling Therapeutics raised $123 million in a Series C financing round to move its oral drug candidate for thyroid eye disease forward. The capital will fund development of linsitinib, the only late…
- Biotech firms race to hire AI-savvy scientists as talent gap widensAI is becoming integral to biotech research and development, prompting companies to seek staff who can blend biology with machine learning and data engineering. Recruiters say the hardest-to-find…